Dolby Laboratories (DLB)
Official siteINDUSTRIALS • SPECIALTY BUSINESS SERVICES • NYSE
Market Cap: $5.96B
Last updated: Nov 17, 2026 at 11:04 AM ET
Dolby Laboratories (DLB) P/E Ratio & Valuation History
Dolby Laboratories (DLB) trades at 15.9x trailing earnings and 4.3x sales. Its P/E of 15.9x is below its 5-year median of 21.7x. Its forward P/E is 13.8x. The median P/E across 11 similar companies is 21.4x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 15.2% higher over the next year. Its free cash flow yield is 6.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 15.9x |
| Forward P/E | 13.8x |
| Price to sales | 4.3x |
| Price to book | 2.2x |
| EV/EBITDA | 14.1x |
| Price to FCF | 14.7x |
| EV/FCF | 13.0x |
| PEG | 2.1 |
| FCF yield | 6.8% |
Historical Medians
Against its 10-year medians, its P/E is 28.4% below 22.2x, its P/S is 20.4% below 5.4x and its P/B is 26.7% below 3.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 15.9x | 21.7x | 22.2x |
| P/S | 4.3x | 5.9x | 5.4x |
| P/B | 2.2x | 3.0x | 3.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 15.4x in 2025 to 29.7x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $64.22 | 15.4x | 4.6x | 2.4x |
| 2024 | $78.10 | 19.9x | 5.7x | 3.0x |
| 2023 | $86.18 | 24.8x | 6.5x | 3.5x |
| 2022 | $70.54 | 21.7x | 5.6x | 3.0x |
| 2021 | $95.22 | 29.7x | 7.8x | 3.7x |
| 2020 | $97.13 | 25.4x | 7.8x | 3.8x |
| 2019 | $68.80 | 24.0x | 5.7x | 3.0x |
| 2018 | $61.84 | 21.5x | 3.1x | 2.7x |
| 2017 | $62.00 | 22.7x | 2.9x | 3.1x |
| 2016 | $45.19 | 17.3x | 4.4x | 2.3x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DLB
What is DLB's forward P/E ratio?
Dolby Laboratories has a forward P/E ratio of 13.8x.
Is DLB stock overvalued?
GNG's valuation label for DLB is Undervalued. Its P/E of 15.9x compares with a median of 21.4x across 11 similar companies.
What is DLB's price to sales ratio?
Dolby Laboratories has a price to sales ratio of 4.3x.
What is Dolby Laboratories's average P/E ratio over 5 years?
Dolby Laboratories's median P/E over the last 5 years is 21.7x, from 60 month-end values through Oct 2026.
What is DLB's PEG ratio?
Dolby Laboratories has a PEG ratio of 2.1.
DLB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors